Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

612 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Absolute lymphocyte count at the end of induction therapy is a prognostic factor in childhood acute lymphoblastic leukemia.
Hirase S, Hasegawa D, Takahashi H, Moriwaki K, Saito A, Kozaki A, Ishida T, Yanai T, Kawasaki K, Yamamoto N, Kubokawa I, Mori T, Hayakawa A, Nishimura N, Nishio H, Iijima K, Kosaka Y. Hirase S, et al. Among authors: yanai t. Int J Hematol. 2015 Nov;102(5):594-601. doi: 10.1007/s12185-015-1875-0. Epub 2015 Oct 6. Int J Hematol. 2015. PMID: 26440971 Clinical Trial.
Rab15 alternative splicing is altered in spheres of neuroblastoma cells.
Pham TV, Hartomo TB, Lee MJ, Hasegawa D, Ishida T, Kawasaki K, Kosaka Y, Yamamoto T, Morikawa S, Yamamoto N, Kubokawa I, Mori T, Yanai T, Hayakawa A, Takeshima Y, Iijima K, Matsuo M, Nishio H, Nishimura N. Pham TV, et al. Among authors: yanai t. Oncol Rep. 2012 Jun;27(6):2045-9. doi: 10.3892/or.2012.1731. Epub 2012 Mar 15. Oncol Rep. 2012. PMID: 22427180
Minimal residual disease monitoring in neuroblastoma patients based on the expression of a set of real-time RT-PCR markers in tumor-initiating cells.
Hartomo TB, Kozaki A, Hasegawa D, Van Huyen Pham T, Yamamoto N, Saitoh A, Ishida T, Kawasaki K, Kosaka Y, Ohashi H, Yamamoto T, Morikawa S, Hirase S, Kubokawa I, Mori T, Yanai T, Hayakawa A, Takeshima Y, Iijima K, Matsuo M, Nishio H, Nishimura N. Hartomo TB, et al. Among authors: yanai t. Oncol Rep. 2013 Apr;29(4):1629-36. doi: 10.3892/or.2013.2286. Epub 2013 Feb 12. Oncol Rep. 2013. PMID: 23417100
Rab15 expression correlates with retinoic acid-induced differentiation of neuroblastoma cells.
Nishimura N, Van Huyen Pham T, Hartomo TB, Lee MJ, Hasegawa D, Takeda H, Kawasaki K, Kosaka Y, Yamamoto T, Morikawa S, Yamamoto N, Kubokawa I, Mori T, Yanai T, Hayakawa A, Takeshima Y, Nishio H, Matsuo M. Nishimura N, et al. Among authors: yanai t. Oncol Rep. 2011 Jul;26(1):145-51. doi: 10.3892/or.2011.1255. Epub 2011 Apr 12. Oncol Rep. 2011. PMID: 21491086
Differential expression of minimal residual disease markers in peripheral blood and bone marrow samples from high-risk neuroblastoma patients.
Yamamoto N, Kozaki A, Hartomo TB, Yanai T, Hasegawa D, Kawasaki K, Kosaka Y, Matsuo M, Hirase S, Mori T, Hayakawa A, Iijima K, Nishio H, Nishimura N. Yamamoto N, et al. Among authors: yanai t. Oncol Lett. 2015 Nov;10(5):3228-3232. doi: 10.3892/ol.2015.3710. Epub 2015 Sep 16. Oncol Lett. 2015. PMID: 26722317 Free PMC article.
Early detection of tumor relapse/regrowth by consecutive minimal residual disease monitoring in high-risk neuroblastoma patients.
Hirase S, Saitoh A, Hartomo TB, Kozaki A, Yanai T, Hasegawa D, Kawasaki K, Kosaka Y, Matsuo M, Yamamoto N, Mori T, Hayakawa A, Iijima K, Nishio H, Nishimura N. Hirase S, et al. Among authors: yanai t. Oncol Lett. 2016 Aug;12(2):1119-1123. doi: 10.3892/ol.2016.4682. Epub 2016 Jun 7. Oncol Lett. 2016. PMID: 27446404 Free PMC article.
612 results